Shining a Light on Runaway Prescription Costs

April 12, 2018

(April 12) – Reps. Joann Ginal and Dominique Jackson won voice-vote House approval today for their bill to add some transparency around skyrocketing prices for pharmaceutical drugs. Under HB18-1260, pharmaceuticals companies would be required to provide 90 days’ notice to the public when they increase the price of a drug by 10 percent over two

House Passes Buckner Bill to Cut High Rx Costs

April 5, 2018

(April 5) – The Drug Costs Savings Act, Rep. Janet Buckner’s bill to increase cost transparency around prescription drugs, passed the House today with strong bipartisan support. HB18-1284, part of the House Democrats’ agenda to control health care costs and protect consumers, allows a pharmacist to disclose a customer’s share of the cost of a

Shedding Light on the Dark Art of Insulin Pricing

March 23, 2018

(March 22) – Rep. Dylan Roberts’ bill to add transparency around drug pricing for Coloradans with diabetes passed the House Health, Insurance & Environment Committee today. About 200,000 Coloradans take insulin, a life-or-death drug for all Type 1 diabetes patients and for many Type 2 patients. HB18-1009, a part of the House Democrats’ consumer protection